REPORT ID 4810

EMEA (Europe, Middle East and Africa) Edible Vaccine Market Report 2017

Publish Date
19-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the EMEA Edible Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Edible Vaccine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Edible Vaccine market competition by top manufacturers/players, with Edible Vaccine sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Sanofi
    Merck
    Merial
    Santa Cruz Animal Health
    Ceva
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Inactivated Vaccines
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Medical Care
    Livestock
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Edible Vaccine Market Report 2017
1 Edible Vaccine Overview
    1.1 Product Overview and Scope of Edible Vaccine
    1.2 Classification of Edible Vaccine
        1.2.1 EMEA Edible Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Edible Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Inactivated Vaccines
        1.2.4 Others
    1.3 EMEA Edible Vaccine Market by Application/End Users
        1.3.1 EMEA Edible Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Medical Care
        1.3.3 Livestock
        1.3.4 Others
    1.4 EMEA Edible Vaccine Market by Region
        1.4.1 EMEA Edible Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Edible Vaccine (2012-2022)
        1.5.1 EMEA Edible Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Edible Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA Edible Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Edible Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA Edible Vaccine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Edible Vaccine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Edible Vaccine Sale Price by Players (2012-2017)
    2.2 EMEA Edible Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Edible Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Edible Vaccine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Edible Vaccine Sale Price by Type (2012-2017)
    2.3 EMEA Edible Vaccine (Volume) by Application
    2.4 EMEA Edible Vaccine (Volume and Value) by Region
        2.4.1 EMEA Edible Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Edible Vaccine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Edible Vaccine Sales Price by Region (2012-2017)

3 Europe Edible Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Edible Vaccine Sales and Value (2012-2017)
        3.1.1 Europe Edible Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Edible Vaccine Revenue and Growth Rate (2012-2017)
    3.2 Europe Edible Vaccine Sales and Market Share by Type
    3.3 Europe Edible Vaccine Sales and Market Share by Application
    3.4 Europe Edible Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Edible Vaccine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Edible Vaccine Revenue by Countries (2012-2017)
        3.4.3 Germany Edible Vaccine Sales and Growth Rate (2012-2017)
        3.4.4 France Edible Vaccine Sales and Growth Rate (2012-2017)
        3.4.5 UK Edible Vaccine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Edible Vaccine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Edible Vaccine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Edible Vaccine Sales and Growth Rate (2012-2017)

4 Middle East Edible Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Edible Vaccine Sales and Value (2012-2017)
        4.1.1 Middle East Edible Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Edible Vaccine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Edible Vaccine Sales and Market Share by Type
    4.3 Middle East Edible Vaccine Sales and Market Share by Application
    4.4 Middle East Edible Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Edible Vaccine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Edible Vaccine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Edible Vaccine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Edible Vaccine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Edible Vaccine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Edible Vaccine Sales and Growth Rate (2012-2017)

5 Africa Edible Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Edible Vaccine Sales and Value (2012-2017)
        5.1.1 Africa Edible Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Edible Vaccine Revenue and Growth Rate (2012-2017)
    5.2 Africa Edible Vaccine Sales and Market Share by Type
    5.3 Africa Edible Vaccine Sales and Market Share by Application
    5.4 Africa Edible Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Edible Vaccine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Edible Vaccine Revenue by Countries (2012-2017)
        5.4.3 South Africa Edible Vaccine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Edible Vaccine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Edible Vaccine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Edible Vaccine Sales and Growth Rate (2012-2017)

6 EMEA Edible Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 GSK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Edible Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GSK Edible Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Edible Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Edible Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Edible Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck Edible Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merial
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Edible Vaccine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merial Edible Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Santa Cruz Animal Health
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Edible Vaccine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Santa Cruz Animal Health Edible Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Ceva
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Edible Vaccine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Ceva Edible Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Edible Vaccine Manufacturing Cost Analysis
    7.1 Edible Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Edible Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Edible Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Edible Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Edible Vaccine Market Forecast (2017-2022)
    11.1 EMEA Edible Vaccine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Edible Vaccine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Edible Vaccine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Edible Vaccine Price and Trend Forecast (2017-2022)
    11.2 EMEA Edible Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Edible Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Edible Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Edible Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Edible Vaccine Sales Forecast by Type (2017-2022)
    11.7 EMEA Edible Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer